Revenue: The sum of all revenue fields included for a company's operating activities.
Amphastar Pharmaceuticals, Inc. (AMPH) had Revenue of $731.97M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$731.97M |
$159.52M |
|
$358.11M |
|
$373.86M |
|
$526.55M |
|
$205.42M |
|
$-15.65M |
|
$189.76M |
|
$189.76M |
|
$160.09M |
|
$159.52M |
|
$159.52M |
|
$160.09M |
|
$205.42M |
|
$264.42M |
|
48.43M |
|
52.06M |
|
$3.29 |
|
$3.06 |
|
| Balance Sheet Financials | |
$534.07M |
|
$297.35M |
|
$1.04B |
|
$1.58B |
|
$173.76M |
|
$601.63M |
|
$671.41M |
|
$845.17M |
|
$732.30M |
|
$141.64M |
|
$732.30M |
|
47.62M |
|
| Cash Flow Statement Financials | |
$213.39M |
|
$-124.93M |
|
$-80.95M |
|
$144.53M |
|
$151.84M |
|
$7.31M |
|
$24.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.07 |
|
-- |
|
-- |
|
0.45 |
|
0.82 |
|
51.08% |
|
28.06% |
|
28.06% |
|
36.12% |
|
25.93% |
|
21.79% |
|
$172.34M |
|
-- |
|
-- |
|
-- |
|
0.46 |
|
2.33 |
|
5.30 |
|
68.83 |
|
21.78% |
|
112.62% |
|
10.11% |
|
11.96% |
|
$15.38 |
|
$3.31 |
|
$4.10 |
|